Wei Y, Li Y, Yan L, et al
PLoS ONE 7(10):e48279 Taghizadeh F, Hosseinimehr SJ, Zargari M, Karimpour Malekshah A, Mirzaei M, Talebpour Amiri F (2021) Alleviation of cisplatin-induced hepatotoxicity by gliclazide: Involvement of oxidative stress and caspase-3 activity
The repeated subcutaneous injection of these peptides for 21 days significantly decreased body weight and significantly changed their body weight reduction ratio (semaglutide, 19.7 4.1%
However, its not a full coaching program, so you wont get ongoing nutrition or behavioral support
The Monitoring Program includes substances which are not on the Prohibited List, but that WADA wishes to monitor in order to detect potential patterns of misuse in sport. A spokesperson for Novo Nordisk said in a statement that the pharmaceutical company, which produces and distributes GLP-1s, agreed with WADAs decision to monitor GLP-1 usage: We are supportive of the WADA recommendation, and we strongly discourage use/promotion outside the indicated population and approved label. Advertisement A spokesperson for Eli Lilly, another company that manufactures and distributes GLP-1s, said: Zepbound (tirzepatide) and Foundayo (orforglipron) are indicated for use, along with diet and exercise, for adults with obesity or overweight and a weight-related comorbidity
GLP-1 analogs have triggered an unprecedented revolution in metabolic control, one of the largest markets in the pharmaceutical sector
